Kawanabe, Yoshifumi, Nobuo Hashimoto, and Tomoh Masaki. Role of phosphoinositide 3-kinase in the nonselective cation channel activation by endothelin-1/endothelinB receptor. Am J Physiol Cell Physiol 284: C506-C510, 2003; 10.1152/ajpcell.00384.2002We recently demonstrated that endothelin-1 (ET-1) activates two types of Ca 2ϩ -permeable nonselective cation channel (designated NSCC-1 and NSCC-2) in Chinese hamster ovarian cells expressing endothelinB receptor (CHO-ETBR). These channels can be discriminated using the Ca 2ϩ channel blockers, LOE 908 and SK&F 96365. LOE 908 is a blocker of NSCC-1 and NSCC-2, whereas SK&F 96365 is a blocker of NSCC-2. In this study, we investigated the possible role of phosphoinositide 3-kinase (PI3K) in the ET-1-induced activation of NSCCs in CHO-ETBR using wortmannin and LY-294002, inhibitors of PI3K. ET-1-induced Ca 2ϩ influx was partially inhibited in CHO-ETBR pretreated with wortmannin or LY-294002. In contrast, addition of wortmannin or LY-294002 after stimulation with ET-1 did not suppress Ca 2ϩ influx. The Ca 2ϩ channels activated by ET-1 in wortmannin-or LY-294002-treated CHO-ETBR were sensitive to LOE 908 and resistant to SK&F 96365. In conclusion, NSCC-2 is stimulated by ET-1 via PI3K-dependent cascade, whereas NSCC-1 is stimulated independently of the PI3K pathway. Moreover, PI3K seems to be required for the initiation of the Ca 2ϩ entry through NSCC-2 but not for its maintenance.
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endothelin-1; endothelinB receptor; phosphoinositide 3-kinase; nonselective cation channel ENDOTHELIN-1 (ET-1) was discovered as a potent vasoconstricting peptide secreted from endothelial cells (17) . It is generally accepted that ET-1 may play a role in the pathogenesis of certain clinical conditions such as hyperlipoproteinemia, atherosclerosis, stroke, cerebral vasospasm, and tumor growth (2, 9) . We demonstrated recently that the extracellular Ca 2ϩ influx is required to ET-1-induced vascular contraction and mitogenesis (4, 6) . These results indicate that if there exist pathways for activation of Ca 2ϩ channels with ET-1 to increase Ca 2ϩ influx, the blockade of these pathways may provide a new strategy for treatment of some diseases involving ET-1 as a pathogenesis. We recently demonstrated that the sustained increase in intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) caused by ET-1 results from Ca 2ϩ entry through two types of Ca 2ϩ -permeable nonselective cation channel (designated NSCC-1 and NSCC-2) in Chinese hamster ovarian (CHO) cells stably expressing human endothelin B receptors (CHO-ET B R) (7) . Importantly, these channels can be distinguished in terms of the sensitivity to the Ca 2ϩ channel blockers SK&F 96365 and LOE 908. NSCC-1 is sensitive to LOE 908 and resistant to SK&F 96365, and NSCC-2 is sensitive to both LOE 908 and SK&F 96365 (7) . The types of G␣ protein involved in activation of NSCC-1 and NSCC-2 are different in CHO-ET B R. NSCC-1 is activated via the G 13 -dependent pathway, and NSCC-2 is activated via both the G q /phospholipase C (PLC)-and the G 13 -dependent pathway (5). However, less is known about intracellular signaling pathways that regulate the activation of these Ca 2ϩ channels. Previous reports have demonstrated that phosphoinositide 3-kinase (PI3K) plays important roles for stimulation of L-type voltage-operated Ca 2ϩ channels with angiotensin (12, 16 ) and for T cell Ca 2ϩ signaling via the phosphatidylinositol 3,4,5-trisphosphate-sensitive Ca 2ϩ entry pathway (3). We thus examined whether the PI3K-dependent pathway is involved in the activation of NSCC-1, NSCC-2, or both, with ET-1 in CHO-ET B R.
MATERIALS AND METHODS
Cell culture. Stable expression of ETBR or unpalmitoylated mutant ETBR (SerETBR) in CHO cells was accomplished as described previously (5, 7, 11) . CHO-ETBR were routinely maintained in F-12 medium supplemented with 10% fetal calf serum under a humidified atmosphere of 5% CO 2-95% air.
Monitoring of [Ca 2ϩ ]i. The [Ca 2ϩ ]i was monitored using the fluorescent probe, fluo 3, as described previously (7). Briefly, the cells were loaded with fluo 3 by incubating the cells with 10 M fluo 3-AM at 37°C under reduced light for 30 min. After being washed, the cells were suspended at a density of ϳ2 ϫ 10 7 cells/ml, and 0.5-ml aliquots were used for measurement of fluorescence by a CAF 110 spectrophotometer (JASCO, Tokyo, Japan) with an excitation wavelength of 490 nm and an emission wavelength of 540 nm. At the end of the experiment, Triton X-100 and subsequently EGTA were added at a final concentration of 0.1% and 5 mM, respectively, to obtain the maximum fluorescence (Fmax) and the minimum fluorescence (Fmin). The [Ca 2ϩ ]i was determined by the equilibrium equation
where F is the experimental value of fluorescence and K d was defined as 0.4 M (10). Drugs. LOE 908 was kindly provided by Boehringer Ingelheim (Ingelheim, Germany). Other chemicals were commercially obtained from the following sources: ET-1 from Peptide Institute (Osaka, Japan), SK&F 96365 from Biomol (Plymouth Meeting, PA), fluo 3-AM from Dojindo Laboratories (Kumamoto, Japan), wortmannin from Wako (Osaka, Japan), and LY-294002 from Sigma (St. Louis, MO).
Statistical analysis. All results were expressed as means Ϯ SE. The data were subjected to a two-way analysis of variance, and when a significant F value was encountered, the Newman-Keuls multiple-range test was used to test for significant differences between treatment groups. A probability level of P Ͻ 0.05 was considered statistically significant.
RESULTS

Effects of wortmannin on the ET-1-induced increase in [Ca
2ϩ
] i in CHO-ET B R. ET-1 at 10 nM induced a biphasic increase in [Ca 2ϩ ] i consisting of an initial transient peak and a subsequent sustained increase in both CHO-ET B R and CHO-ET B R preincubated with wortmannin ( Fig. 1, A and B) . The magnitude of the transient peak and that of the sustained increase in [Ca 2ϩ ] i depended on the concentration of ET-1 ( Fig. 1,  C and D) . In experiments performed on cells incubated (Fig. 1C) . On the other hand, the magnitude of sustained increase in [Ca 2ϩ ] i caused by 10 nM ET-1 in CHO-ET B R preincubated with wortmannin was ϳ35% of that in CHO-ET B R (Figs. 1D and 2B ). In contrast, addition of wortmannin after stimulation with ET-1 did not affect to the sustained increase in [Ca 2ϩ ] i (Fig. 1A) . 
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In CHO-ET B R, wortmannin inhibited ET-1-induced sustained increase in [Ca 2ϩ ] i in a concentration-dependent manner with an IC 50 values of 28.3 Ϯ 3.2 nM, and the maximal inhibition (ϳ65% of control) was seen at concentrations Ն1 M (Fig. 2) . In contrast, wortmannin up to 1 M failed to suppress ET-1-induced transient increase in [Ca 2ϩ ] i ( Fig. 2A) . [Ca 2ϩ ] i in CHO-ET B R. We also used LY-294002 to evaluate the involvement of PI3K on ET-1-induced extracellular Ca 2ϩ influx. LY-294002 at 50 M inhibited PI3K activation completely in CHO cells (8) . The magnitudes of ET-1-induced transient increase in [Ca 2ϩ ] i in CHO-ET B R preincubated with 50 M LY-294002 were similar to those in CHO-ET B R (Fig. 3,  A-C) . On the other hand, 50 M LY-294002 inhibited ET-1-induced sustained increase in [Ca 2ϩ ] i , and ϳ65% inhibition was obtained (Fig. 3, B and D) . Moreover, addition of LY-294002 after stimulation with ET-1 did not affect the sustained increase in [Ca 2ϩ ] i (Fig. 3A) . (Fig. 4A) . In CHO-ET B R pretreated with 0.1 M wortmannin, the SK&F 96365-sensitive part of ET-1-induced sustained increase in [Ca 2ϩ ] i was inhibited partially (Fig. 4B) . The ET-1-induced sustained increase in [Ca 2ϩ ] i in CHO-ET B R preincubated with 1 M wortmannin was inhibited by LOE 908 in a concentration-dependent manner, and complete inhibition was observed at concentrations Ն10 M (Fig. 4, C and  D) . In contrast, SK&F 96365 up to 10 M failed to inhibit ET-1-induced sustained increase in [Ca 2ϩ ] i in CHO-ET B R preincubated with 1 M wortmannin (Fig.  4, C and D) . These results suggest that activation of NSCC-1 with ET-1 is wortmannin resistant, whereas that of NSCC-2 is wortmannin sensitive. In CHO-ET B R preincubated with 50 M LY-294002, ET-1-induced sustained increase in [Ca 2ϩ ] i was also sensitive to LOE 908 and resistant to SK&F 96365 (data not shown).
Effects of LY-294002 on the ET-1-induced increase in
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Effects of wortmannin on ET-1-induced sustained increase in [Ca 2ϩ ] i in CHO cells expressing unpalmitoylated mutant ET B R (SerET B R).
To assess the effects of wortmannin on the activation of NSCC-1, we used CHO-SerET B R. SerET B R is unpalmitoylated because of substitution of all the cysteine residues to serine ( (5) . Wortmannin at 1 M did not affect ET-1-induced sustained increase in [Ca 2ϩ ] i in CHO-SerET B R (Fig. 5) . LOE 908 at 10 M inhibited ET-1-induced sustained increase in [Ca 2ϩ ] i completely in wortmannin-treated CHO-SerET B R (Fig. 5) . On the other hand, SK&F 96365 at 10 M failed to inhibit ET-1-induced sustained increase in [Ca 2ϩ ] i in these cells (Fig. 5) .
DISCUSSION
In this study, we focused on the involvement of PI3K in the Ca 2ϩ channel activation caused by ET-1 in CHO-ET B R because PI3K plays important roles for stimulation of extracellular Ca 2ϩ influx. From the data that addition of wortmannin or LY-294002 after stimulation with ET-1 did not suppress sustained increase in [Ca 2ϩ ] i (Figs. 1A and 3A) , wortmannin or LY-294002 seems not to directly act as Ca 2ϩ channel blocker. Therefore, wortmannin and LY-294002 may be efficient tools for studying intracellular mechanisms involved in Ca 2ϩ channel activation by ET-1. Moreover, PI3K seems to be required for the initiation of the Ca 2ϩ entry but not for its maintenance. The inhibitory effects of wortmannin on ET-1-induced sustained increase in [Ca 2ϩ ] i may be due to its inhibition of PI3K, judging from the following data: 1) wortmannin is generally accepted as a PI3K inhibitor (14) . Moreover, at nanomolar concentrations, wortmannin acts specif- ically on PI3K (18); 2) another PI3K inhibitor, LY-294002, also inhibited the wortmannin-sensitive part of ET-1-induced sustained increase in [Ca 2ϩ ] i ; and 3) the IC 50 values (ϳ30 nM) and maximal effective concentration (1 M) of wortmannin for ET-1-induced sustained increase in [Ca 2ϩ ] i in CHO-ET B R ( Fig. 2A) were similar to those for ET-1-induced phosphatidylinositol triphosphate (PIP 3 ) formation as an index of PI3K activity (13) .
As wortmannin and LY-294002 partially suppressed ET-1-induced sustained increase in [Ca 2ϩ ] i (Figs. 1-3 ), ET-1 induces extracellular Ca 2ϩ influx through NSCCs via two different pathways, PI3K-dependent and -independent, in CHO-ET B R. On the basis of the sensitivity to SK&F 96365 and LOE 908, the PI3K-inhibitor resistant part of sustained increase in [Ca 2ϩ ] i was due to Ca 2ϩ influx through NSCC-1 (LOE 908-sensitive and SK&F 96365-resistant) (Fig. 4, C and D) . Thus Ca 2ϩ influx through NSCC-2 was the PI3K inhibitorsensitive part. These results indicate that PI3K may play important roles for ET-1-induced activation of NSCC-2. The result that wortmannin failed to inhibit the activation of NSCC-1 by ET-1 in CHO-SerET B R (Fig. 5) is consistent with this indication. NSCC-2 activation by ET-1 involves G q /PLC-dependent cascade and depends on mobilization of Ca 2ϩ from the intracellular Ca 2ϩ store in CHO-ET B R (5). Moreover, it is generally accepted that G␤␥ is involved in PI3K activation (1, 15) . Therefore, G␤␥ as well as G␣ may play important roles for NSCC-2 activation by ET-1.
In conclusion, NSCC-2 are stimulated by ET-1 via PI3K-dependent cascade, whereas NSCC-1 is stimulated via PI3K-independent cascade. Moreover, PI3K seems to be required for the initiation of the Ca 2ϩ entry but not for its maintenance.
